{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System",
        "BD Phoenix\u2122 Automated Microbiology System Erythromycin (0.0156-4 \u03bcg/mL)",
        "BD Phoenix\u2122M Automated Microbiology System for use with the antimicrobial agent erythromycin (0.0156-4 \u03bcg/mL) - Streptococcus ID/AST or AST only Phoenix Panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K051109",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "June 16, 2005",
    "Summary Letter Received Date": "May 2, 2005",
    "Submission Date": "April 29, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Erythromycin"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates of Gram-negative aerobic and facultative anaerobic bacteria",
        "Pure culture isolates of Gram-positive bacteria (Staphylococcus, Enterococcus, Streptococcus)",
        "Streptococcus pneumoniae",
        "Streptococcus pyogenes"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument and software"
    ],
    "Method(s)/Technology(ies)": [
        "Automated broth-based microdilution",
        "Redox indicator for growth detection"
    ],
    "Methodologies": [
        "Minimal inhibitory concentration (MIC) determination",
        "Antimicrobial susceptibility testing (AST)"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix\u2122M Automated Microbiology System using erythromycin for antimicrobial susceptibility testing of Streptococcus isolates",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) for most Gram-negative and Gram-positive bacteria from pure culture, including Streptococcus ID/AST or AST Phoenix panels with erythromycin",
    "fda_folder": "Microbiology"
}